AVGO Q1 2026 Earnings EPS Miss and Tepid Stock Response Amid Mixed Signals FR Q1 2026 Earnings Massive EPS Beat Surprises Market LUCD Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Status Core Laboratories Q1 2026 Earnings EPS Misses Estimates as Market Challenges Persist Silo Pharma Inc SILO Q4 2023 Earnings Widening Losses as PreRevenue Biotech Focuses on Pipeline Progress NTSK Q4 2025 Earnings Narrowed Loss and Positive Market Sentiment